PAREXEL International (United Kingdom)

PAREXEL International (United Kingdom)

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PAREXEL International (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

77%


Total
Publications

572


Total Open
Publications

442


Total
Citations

4.7K


Open Access
Percentage

77%


Total
Publications

572


Total Open
Publications

442


Total
Citations

4.7K

Wikipedia

Website

download

Breakdown

58% 16% 3% 23%

Publisher Open

58%

Both

16%

Other Platform Open

3%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

12%OA Journal

OA Journal 12%

50

Hybrid 78%

332

No Guarantees 10%

42

Other Platform Open

Domain 80%

89

Institution 25%

28

Public 14%

16

Other Internet 7%

8

Preprint 6%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
89
Europe PMC
Domain
57
Semantic Scholar
Public
12
University College London - UCL Discovery
Institution
10
University of Birmingham - University of Birmingham Research Portal
Institution
6
whiterose.ac.uk OAI-PMH Repository
Institution
5
Figshare
Public
5
University of Southampton - ePrints Soton
Institution
3
University of Leeds, The University of Sheffield, University of York - White Rose Research Online
Institution
3
Erasmus University Rotterdam - EUR Research Repository
Institution
3
1 / 5

Data updated 17 June 2024

Share

Share

Share